Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-24-041787)

Filing Details

Accession Number:: 0000950170-24-041787
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-04-04 16:00:05
Reporting Period:: 2024-04-02

Accepted Time:: 2024-04-04 16:00:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1527599	Synlogic Inc.	SYBX	Pharmaceutical Preparations (2834)	261824804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1820122	Antoine Awad	C/O Synlogic, Inc. 301 Binney Street, Suite 402 Cambridge MA 02142	Chief Operating Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-04-02	372	$1.73	33,859	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the number of shares sold by the reporting person on April 2, 2024 to cover the tax liability in connection with the vesting of three restricted stock awards, vesting on April 1, 2024, that were granted in 2020, 2021 and 2022.